UNSPSC 51162405: Acetaminophen/dextromethorphan/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE515. This VA Drug Class (RE515) classifies this compound as belonging to the group DECONGESTANT/ANTITUSSIVE/ANALGESIC.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162405 Acetaminophen/dextromethorphan/phenylpropanolamine is a Commodity code that in practice encompasses naloxone, safe drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products procured by state and local health and human services agencies. State and local buyers under this code include county health departments and state-administered cooperative purchasing alliances serving multiple member jurisdictions. The actual work being solicited spans annual supply contracts for emergency-response pharmaceuticals and broad-based OTC and generic pharmaceutical product agreements distributed through authorized wholesalers to participating state and local government facilities.

Recent activity appears in Florida and Minnesota. Seminole County, Florida released an IFB on June 30, 2026 (response due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the contract includes a two-year term with optional one-year renewal and requires fixed-fee pricing with E-Verify compliance and specific insurance coverage. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (response due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, requiring vendors to supply through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC with cGMP certification and Drug Supply Chain Security Act compliance; the RFP weights price competitiveness at 75 percent and imposes a 3 percent administrative fee on all contract purchases, with performance penalties ranging from $200 to $1,500 per violation.